EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells

Marina Montagnani Marelli iD, Giangiacomo Beretta iD, Roberta Manuela Moretti iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24054923 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Marina Montagnani Marelli und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milan, Italy. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research (MIUR) Progetto di Eccellenza 2018–2022.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) represents the fifth cause of cancer death in men. Currently, chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor growth by apoptosis induction. However, defects in apoptotic cellular responses frequently lead to drug resistance, which is the main cause of chemotherapy failure. For this reason, trigger non-apoptotic cell death might represent an alternative approach to prevent drug resistance in cancer. Several agents, including natural compounds, have been shown to induce necroptosis in human cancer cells. In this study we evaluated the involvement of necroptosis in anticancer activity of delta-tocotrienol (δ-TT) in PCa cells (DU145 and PC3). Combination therapy is one tool used to overcome therapeutic resistance and drug toxicity. Evaluating the combined effect of δ-TT and docetaxel (DTX), we found that δ-TT potentiates DTX cytotoxicity in DU145 cells. Moreover, δ-TT induces cell death in DU145 cells that have developed DTX resistance (DU-DXR) activating necroptosis. Taken together, obtained data indicate the ability of δ-TT to induce necroptosis in both DU145, PC3 and DU-DXR cell lines. Furthermore, the ability of δ-TT to induce necroptotic cell death may represent a promising therapeutical approach to overcome DTX chemoresistance in PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsAntineoplastic AgentsMaleHumansDocetaxelDrug Resistance, NeoplasmNecroptosisApoptosisCell Line, TumorVitamin E

Stichwörter der Autor:innen

chemoresistancedelta-tocotrienoldocetaxelnecroptosisprostate cancer

Substanzen

DocetaxelAntineoplastic Agentstocotrienol, deltaVitamin E

Autor:innen und Institutionen

  • Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milan, Italy.
  • Department of Environmental Science and Policy, Università degli Studi di Milano, 20133 Milan, Italy.

ORCID-Profile: Marina Montagnani Marelli, Giangiacomo Beretta, Roberta Manuela Moretti

Förderung

  • Italian Ministry of University and Research (MIUR) Progetto di Eccellenza 2018–2022

Zitieren

APA

Montagnani Marelli, M., Beretta, G., & Moretti, R. M. (2023). Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054923

Vancouver

Montagnani Marelli M, Beretta G, Moretti RM. Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054923

BibTeX
@article{MontagnaniMarelli2023,
  author = {Montagnani Marelli, Marina and Beretta, Giangiacomo and Moretti, Roberta Manuela},
  title = {Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24054923}
}
Kostenlos starten →